Show simple item record

dc.contributor.authorLawson, Grahamen
dc.contributor.authorCocks, Elizabethen
dc.contributor.authorTanna, Sangeetaen
dc.date.accessioned2013-11-05T16:19:50Z
dc.date.available2013-11-05T16:19:50Z
dc.date.issued2013-07
dc.identifier.citationLawson, G., Cocks, E. and Tanna, S. (2013) Liquid chromatography-high resolution mass spectrometry applied to therapeutic drug monitoring using DBS sampling. Proceedngs of The 24th International Symposium on Pharmaceutical and Biomedical Analysis, 30 June-3 July 2013.en
dc.identifier.urihttp://hdl.handle.net/2086/9307
dc.description.abstractIntroduction: Quantitative dried blood spot (DBS) analysis was used to investigate if the accurate mass capability (±2ppm m/z) of high resolution mass spectrometry (HRMS) would provide compound specificity comparable to the multiple reaction monitoring (mrm) approach used with a triple quadrupole mass spectrometer. Some initial clinical data from DBS for selected drugs is reported. Methods: Known concentrations of atenolol, caffeine, captopril and dexamethasone in whole blood were prepared as DBS samples. The target drugs were solvent extracted from punched DBS disks and analysed in positive electrospray ionisation mode to prepare calibration graphs based on TOF detection. Individual LC conditions were developed and applied to dried blood spots obtained from neonate patient samples to obtain pharmacokinetic data and from adults to assess adherence to therapy. Results: The extraction efficiency for the recovery of all target drugs from spiked dried blood spots was >90% and the drugs were stable in DBS for at least 12 weeks at room temperature. Use of the stabiliser 1,4 dithiothreitol (DTT) in the paper and extraction solvent was essential for captopril analyses. Validation using spiked blood calibration standards showed good accuracy, precision and linearity. MH+ m/z LoQ (S/N >10) Injection volume Atenolol 276.1703 50.0ng/ml 5l Caffeine 195.0883 100.0ng/ml 5l Captopril 218.0845 20.0ng/ml 10l Dexamethasone 393.2034 15.0ng/ml 20l Conclusion: Comparison of MS/MS and HRMS data demonstrated good selectivity for the two approaches. It was also possible to re-interrogate the TOF recorded data for other ions without the need to re-run the sample.en
dc.language.isoenen
dc.subjectBlood spot analysisen
dc.subjecttherapeutic drug monitoringen
dc.subjecthigh resolution mass spectrometryen
dc.titleLiquid chromatography-high resolution mass spectrometry applied to therapeutic drug monitoring using DBS samplingen
dc.typeConferenceen
dc.researchgroupPharmacy Practiceen
dc.peerreviewedYesen
dc.funder*en
dc.projectid*en
dc.researchinstituteLeicester Institute for Pharmaceutical Innovation - From Molecules to Practice (LIPI)en


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record